These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8192169)

  • 1. Combinations of drugs in lipid-lowering therapy.
    LaRosa JC
    Am J Med; 1994 May; 96(5):399-400. PubMed ID: 8192169
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging Fixed-Dose Combination Treatments for Hyperlipidemia.
    Pappa E; Rizos CV; Filippatos TD; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):315-322. PubMed ID: 30909733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid therapy. Prevention of arteriosclerotic cardiovascular diseases].
    Windler E
    Internist (Berl); 2001 Jan; 42(1):92-110. PubMed ID: 11271625
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and safety of simvastatin in patients with hypercholesterolemia (results of a Multicenter Clinical Study)].
    Kukharchuk VV; Bubnova MG; Katel'nitskaia LI; Nikitin IuP; Ol'binskaia LI;
    Kardiologiia; 2003; 43(5):42-7. PubMed ID: 12891239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals.
    Schectman G; Hiatt J
    Am J Med; 1996 Feb; 100(2):197-204. PubMed ID: 8629655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Becoming more "goal-oriented" in therapy of dyslipidemias: results of the Hungarian MULTI GAP 2010].
    Reiber I; Paragh G; Márk L; Pados G
    Orv Hetil; 2011 May; 152(21):822-7. PubMed ID: 21546340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Currently available lipid-lowering agents.
    Levy RI
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of hyperlipidemia].
    Kajiyama G; Horiuchi I
    Nihon Rinsho; 1990 Nov; 48(11):2620-8. PubMed ID: 2270030
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of lipid-lowering drugs in children.
    Brown WV; Wilson DP; Freemark M; Kwiterovich PO
    J Clin Lipidol; 2010; 4(6):449-61. PubMed ID: 21122691
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of lipid-lowering treatment in France--the CEPHEUS study.
    Ferrières J; Gousse ET; Fabry C; Hermans MP;
    Arch Cardiovasc Dis; 2008 Sep; 101(9):557-63. PubMed ID: 19041840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update of lipid lowering therapy].
    Riesen WF; Mordasini RC
    Praxis (Bern 1994); 2008 Nov; 97(22):1179-84. PubMed ID: 18979436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
    Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for Lipid-Lowering Therapy Intensification Rarely Followed.
    Slomski A
    JAMA; 2021 Sep; 326(9):800. PubMed ID: 34547090
    [No Abstract]   [Full Text] [Related]  

  • 17. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels.
    Roberts WC
    Am J Cardiol; 1994 Mar; 73(8):623-4. PubMed ID: 8147319
    [No Abstract]   [Full Text] [Related]  

  • 20. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy.
    Blair SN; Capuzzi DM; Gottlieb SO; Nguyen T; Morgan JM; Cater NB
    Am J Cardiol; 2000 Jul; 86(1):46-52. PubMed ID: 10867091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.